Abstract
Purpose
Over the past two decades, lamellar keratoplasty procedures, such as Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) and Descemet's Membrane Endothelial Keratoplasty (DMEK) as well as Deep Anterior Lamellar Keratoplasty (DALK), have become an integral part of clinical practice. With advances in contact lens fitting for keratoconus management and the implementation of UVA-Riboflavin Crosslinking (CXL), the landscape of keratoplasty indications is undergoing changes. Procedures and indications in a single tertiary care center over the past two decades are reviewed in this retrospective analysis. Methods: Retrospective analysis utilized anonymized electronic data from the LIONS cornea bank Baden-Württemberg, Eye Center Freiburg, spanning from beginning of 2004 to end of 2023. The primary focus was on surgical procedures and indications for keratoplasty.
Results
The study encompassed a comprehensive analysis of 7130 corneal transplants. Penetrating keratoplasty (PK) exhibited a significant decline from 95% (n = 206, 2004) to 11% (n = 46, 2023), while DMEK increased from 48% (n = 157, 2012) to 82% (n = 347, 2023). Fuchs endothelial dystrophy (FED) emerged as the dominant indication, witnessing a significant increase from 24% (2004, n = 39) to 72% (2023, n = 288). Conversely, keratoconus (KC) showed a reciprocal change from 25% (2004, n = 40) to 4% (2023, n = 17). PK demonstrated a noteworthy indication shift in descending order from Bullous Keratopathy (BK), FED, and KC in 2004 to KC, graft failure, corneal scars, and ulcers in 2023. Repeat keratoplasty following DMEK remained rare, but a discernible upward trend was observed for PK.
Conclusion
This retrospective analysis highlights significant changes in both keratoplasty indications and techniques over the past two decades. DMEK has emerged as a successful intervention for treating endothelial diseases, while PK retains its qualitative indispensability for a wide range of indications. Modern corneal banks are urged to maintain a robust supply of grafts for all surgical techniques in anticipation of potential increased demand in the future, particularly for repeat keratoplasties.
Key messages
What is known
• Over the past two decades, lamellar keratoplasty procedures such as DSAEK and DMEK have increasingly replaced penetrating keratoplasty (PK) in clinical practice due to their improved outcomes and reduced complications for certain indications.
New Findings
• Our study reveals a significant shift in keratoplasty indications, with Fuchs endothelial dystrophy (FED) emerging as the predominant indication, increasing from 24% in 2004 to 72% in 2023, while keratoconus (KC) declined from 25 to 4% during the same period.
• Penetrating keratoplasty (PK) has shown a marked decline in use, dropping from 95% of keratoplasties in 2004 to 11% in 2023, whereas DMEK has grown to represent 82% of procedures in 2023.
• Despite the rise of DMEK, PK remains vital for a broad spectrum of indications, highlighting the necessity for corneal banks to maintain a versatile supply of grafts to meet diverse clinical needs, particularly in cases of repeat keratoplasties.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Background
Keratoplasty, an essential surgical procedure to treat corneal disorders by replacing damaged or diseased corneal tissue, has a rich historical trajectory marked by the evolution of two primary techniques: penetrating as well as lamellar keratoplasty.
Penetrating keratoplasty finds its roots in the late nineteenth century, notably with Eduard Zirm's pioneering successful procedure in 1905 [1]. This landmark event served as a cornerstone, prompting continual refinements in surgical techniques, tissue preservation modalities, and post-operative care, continuously improving efficacy and success rates of penetrating keratoplasty [2].
The emergence of lamellar keratoplasty as an alternative approach to selectively replace affected corneal layers dates back to the 1940s [3]. Its rise has been aided by advances in microsurgical instrumentation and a deeper understanding of corneal anatomy. This technique has gained much attention and acceptance in the field with the aim of reducing the risk of graft rejection and better preserving the structural integrity of the host cornea [4].
The evolution of both penetrating as well as lamellar keratoplasty owes much to technological breakthroughs, including the integration of femtosecond laser technology for precise corneal dissection and the evolution of selective endothelial keratoplasty techniques [5,6,7,8,9,10].
Continuous research endeavors in keratoplasty strive to optimize surgical outcomes, mitigate complications, and broaden the spectrum of indications for corneal transplantation. These ongoing advances have positioned keratoplasty as a highly sophisticated and effective surgical modality for treating various corneal pathologies, profoundly improving visual acuity and overall quality of life for a global population [11,12,13,14].
As recently provided by Flockerzi E et. al. the performed keratoplasties in Germany were analyzed for 2011 to 2021. The data show the substantial increase in the importance of DMEK, which has now overtaken PK [15]. Thus, data show similar trends in German eye centers performing keratoplasties.
Materials and methods
We analyzed the data of the LIONS cornea bank Baden-Württemberg, Eye Center Freiburg, with regards to indication of keratoplasty and surgery techniques. Approval by the Ethics Committee was given by the Albert-Ludwigs-University Freiburg (No. 23–1213-S1-retro). Anonymization of data was performed in accordance with the current data protection regulations prior to further investigations. A descriptive analysis of the collected data was then performed, taking into account the initial indication and distinguishing between different keratoplasty procedures for each year from 2004 to 2023. The respective data are displayed in line and bar charts as a function of the year. For evaluation of the proportion of therapeutic PK over all registered PK, they were defined as performed surgery within 7 days after listing on the waiting list. In addition, we obtained data on the rate of repeat keratoplasties depending on the surgical technique initially performed. Statistical analysis and data plotting was performed using R [16].
Results
We identified a total of 7130 keratoplasties for the period between 2004 and 2023. Overall, the number of corneal grafting procedures increased steadily, starting from 279 procedures in 2010 to 422 in 2023. The number of annual penetrating keratoplasties declined from 206 in 2004 to 46 in 2023. Considering the number of limbo-keratoplasties performed, it becomes apparent that there is no clear trend, as it has remained relatively stable at a low level. In the group of lamellar keratoplasties, DMEK has been the most frequently performed surgical technique since 2012. The number of DMEK performed rose steadily from 157 in 2012 to 347 in 2023 (Fig. 1). As the main representative of anterior lamellar keratoplasty, the number of DALKs undertaken has remained relatively consistent but at low levels. As far as grafts delivered to external centers are concerned, a steady decline has been observed over the last 20 years, although the decrease has been less pronounced in recent years. In the following charts, the grafts that were sent from our LIONS cornea bank Baden-Württemberg, Eye Center Freiburg, to external surgeons for transplantation are categorized as "external patients".
Quantitatively the two most important indications for corneal transplantation are FED with 3516 and KC with 733. With respect to these main indications, there was an increase from 39 (23%) in 2004 to 288 (68%) in 2023 for FED whereas a reciprocal development was determined for KC from 40 (15%) to 17 (4%). Further important indications were the BK as well as therapeutic indications such as perforated ulcers (Fig. 2A).
In 2004, the most relevant indications for PK were BK, FED and KC. There was a significant change in this spectrum over the years, mainly due to the fact the FED is now primarily treated by lamellar keratoplasty. Therefore, in 2023, the main indications were KC, graft failure, corneal scars and ulcers (Fig. 2B). Dermatological diseases, such as ocular pemphigoid, were treated with PK at a low level. In most cases, the only therapeutic option is still limbo-keratoplasty as shown in Fig. 2B or keratoprosthesis, e.g. Boston type 1 keratoprosthesis or osteo-odonto keratoprosthesis, performed in dedicated specialized eye centers [17,18,19,20].
PK was also differentiated between elective PK and therapeutic PK. A comparison of the years 2004 to 2010 with 2011 to 2023 shows a decrease in the relative proportion of PK a chaud. Since 2011, there has been a relatively stable share of therapeutic PK (Fig. 3).
Furthermore, the proportion of repeat keratoplasties was analyzed depending on the surgical method initially performed. For DMEK repeated corneal transplantation was relatively stable from 2013 to 2023. However, the numbers of repeat PK are on the rise in the more recent years (Fig. 4).
Additionally, the air-line distance as a function of postal code of the recipient for all performed keratoplasties showed a significant increase from 2004 to 2010 with a corresponding peak of about 175 km. In the following years a decline to a steady state ranging between 100 to 125 km could be shown. Looking at the travel distance differentiated for PK, Limbo-KP and DMEK similar trends can be observed (Fig. 5).
Discussion
This study analyses the change in indications for corneal transplantation over a period of twenty years and shows a significant change in the spectrum of indications, which is due, among other things, to a rapid change in surgical techniques. The decline in penetrating keratoplasties is matching the overall global trend [22,23,24]. The increase in the relative and absolute importance of DMEK is also in line with previously published data [25,26,27]. Looking at the change in the spectrum of indications leading to surgery, it is surprising that there is a reciprocal development with regard to KC. However, KC is expected to remain the main indication for penetrating keratoplasty. Moreover, PK will remain the gold-standard for therapeutic indications such as corneal ulcers. In other centers similar developments were described [28]. A recent retrospective multicenter analysis clearly shows that eye centers in Germany are now concentrating mainly on posterior lamellar keratoplasty and are primarily performing DMEK as its main representative. In North America and Australia, too, posterior lamellar keratoplasty has been performed predominantly in recent years. It is noticeable, however, that DS(A)EK is the most important method in these regions in the last years with a rising trend for DMEK. This trend was again confirmed in the report of the Eye Bank Association of America for 2023, with more DMEK than DSAEK being performed in the USA in that year for the first time. DALK, as the main representative of anterior lamellar keratoplasty, has been shown to have low but stable numbers over the years, suggesting that DALK retains its relevance for a small range of indications such as moderate keratoconus or anterior corneal scars without Descemet's membrane involvement. This trend is consistent with previously published data [15]. One common feature in all these regions, though, is that PKP is the second most common technology [15, 29,30,31]. Especially corneal ulcers can hardly be compensated by lamellar surgery techniques. With FED being the most important indication quantitatively, the increase of performed DMEK is not yet at its peak, and our data suggest that there will be an ongoing increase in the absolute number of DMEK performed in the coming years. Besides keratoprosthesis the only therapeutic option for existing bilateral limbal stem cell insufficiency, especially in chronic diseases such as ocular pemphigoid, is limbo-keratoplasty. Accordingly, the numbers have remained largely stable over the years, as there is still no established easy alternative, and the long-term results indicate a low graft rejection rate [32].
Comparing the results to other global regions it is striking, that in Northern America the relevance of bullous keratopathy leading to PK is still quantitatively the most important indication. We attribute this to the high quality standard and center-based cataract surgeons as well as the decline of anterior chamber intraocular lenses at our eye center, while in other regions, including the United States, this type of intraocular lens is still prevalent [33].
In the last decade, there was a relative increase of performed penetrating keratoplasties due to KC. This can best be explained by the fact, that the relative proportion of patients with FED leading to PK declined as DMEK is now the gold standard in this case [34].
It is worth noting that the number of PK leading to repeat keratoplasties has increased in recent years, while the proportion of repeat keratoplasties after initially performed DMEK has remained relatively stable. With regard to the shift of patients with FED, who are now usually treated initially with DMEK, it should be borne in mind that the proportion of complicated PKs is increasing and hence the relative number of repeat keratoplasties is rising accordingly.
While the total number of PK performed has decreased over the last two decades, the total number of therapeutic PK has also decreased accordingly. It has also been shown that the relative share of corneal grafts also experienced a negative trend during this period. Nevertheless, it must be emphasized that the proportion has remained relatively stable over the last 10 years. This clearly underlines how important it is for a corneal bank to keep a large variety of corneal buttons in stock, especially for therapeutic indications for performing a PK, as alternative procedures have not yet been established. It is important to note that as certain surgical methods decline in use, it is crucial to maintain the necessary training and surgical expertise to ensure the availability of these techniques when needed.
It must be taken into account that the monocentric design of this study only reveals the trends at LIONS BW cornea bank, Eye Center Freiburg, Nevertheless, similar trends as described above have been identified in other eye centers. It must also be considered that this is only a descriptive retrospective analysis. It is also important to bear in mind that no statement can be made about the indication and surgical technique etc. for transplants sent to external surgeons.
Considering the air-line distance using the postal codes of each patient in the years 2004 to 2010, the distance was constantly rising with a peak of approx. 175 km linear distance. From then on, travel distance slightly declined on a relatively high level of about 100 to 125 km. On the one hand, the data underlines the importance of the eye center for a large area, especially when new techniques such as DMEK are being established.
Conclusion
In conclusion, there has been a significant increase in the absolute number of keratoplasties performed over the last two decades. This is partly due to the expansion of surgery indication, patient population, particularly with the introduction of DMEK for the treatment of FED, and partly due to the increased distance traveled by patients. The success of DMEK has also led to a significant change in the range of indications for which keratoplasty is performed, with endothelial keratopathies being the most common. However, it should not be forgotten that PK and DALK play an important role in the treatment of therapeutic indications as well as in the surgical management of KC when contact lens fitting or CXL is not successful.
Abbreviations
- BK:
-
Bullous keratopathy
- CXL:
-
UVA-Riboflavin Crosslinking
- DMEK:
-
Descemet Membrane Endothelial Keratoplasty
- DSAEK:
-
Descemet's Stripping Automated Endothelial Keratoplasty
- FED:
-
Fuchs Endothelial Dystrophy
- KC:
-
Keratoconus
- PK:
-
Penetrating Keratoplasty
References
Zirm EK (1989) Eine erfolgreiche totale Keratoplastik (A successful total keratoplasty). 1906. Refract Corneal Surg 5(4):258–61
Reinprayoon U, Srihatrai P, Satitpitakul V, Puangsricharern V, Wungcharoen T, Kasetsuwan N (2021) Survival Outcome and Prognostic Factors of Corneal Transplantation: A 15-Year Retrospective Cohort Study at King Chulalongkorn Memorial Hospital. Clin Ophthalmol 15:4189–4199. https://doi.org/10.2147/opth.S336986
Singh NP, Said DG, Dua HS (2018) Lamellar keratoplasty techniques. Indian J Ophthalmol 66(9):1239–1250. https://doi.org/10.4103/ijo.IJO_95_18
Henein C, Nanavaty MA (2017) Systematic review comparing penetrating keratoplasty and deep anterior lamellar keratoplasty for management of keratoconus. Cont Lens Anterior Eye 40(1):3–14. https://doi.org/10.1016/j.clae.2016.10.001
Price FW, Price MO (2005) Descemet's stripping with endothelial keratoplasty in 50 eyes: a refractive neutral corneal transplant. J Refract Surg 21(4):339–45
Melles GR et al (1998) A surgical technique for posterior lamellar keratoplasty. Cornea 17(6):618–626. https://doi.org/10.1097/00003226-199811000-00010
Melles GR, Remeijer L, Geerards AJ, Beekhuis WH (2000) A quick surgical technique for deep, anterior lamellar keratoplasty using visco-dissection. Cornea 19(4):427–432. https://doi.org/10.1097/00003226-200007000-00004
Melles GR, Ong TS, Ververs B, van der Wees J (2006) Descemet membrane endothelial keratoplasty (DMEK). Cornea 25(8):987–990. https://doi.org/10.1097/01.ico.0000248385.16896.34
Fernandez MM, Afshari NA (2010) Endothelial Keratoplasty: From DLEK to DMEK. Middle East Afr J Ophthalmol 17(1):5–8. https://doi.org/10.4103/0974-9233.61210
Melles GR, Ong TS, Ververs B, van der Wees J (2008) Preliminary clinical results of Descemet membrane endothelial keratoplasty. Am J Ophthalmol 145(2):222–227. https://doi.org/10.1016/j.ajo.2007.09.021
Armitage WJ et al (2019) High-risk Corneal Transplantation: Recent Developments and Future Possibilities. Transplantation 103(12):2468–2478. https://doi.org/10.1097/tp.0000000000002938
Mendes F et al (2003) Assessment of visual function after corneal transplantation: the quality of life and psychometric assessment after corneal transplantation (Q-PACT) study. Am J Ophthalmol 135(6):785–793. https://doi.org/10.1016/s0002-9394(02)02278-x
Böhringer D, Reinhard T (2013) Long-term keratoplasty graft survival. Ophthalmology 120(1):216. https://doi.org/10.1016/j.ophtha.2012.07.046
Böhringer D, Grotejohann B, Ihorst G, Reinshagen H, Spierings E, Reinhard T (2018) Rejection Prophylaxis in Corneal Transplant. Dtsch Arztebl Int 115(15):259–265. https://doi.org/10.3238/arztebl.2018.0259
Flockerzi E, Turner C, Seitz B, Collaborators GSG, GeKe RSG (2023) Descemet’s membrane endothelial keratoplasty is the predominant keratoplasty procedure in Germany since 2016: a report of the DOG-section cornea and its keratoplasty registry. Br J Ophthalmol 108(5):646–53. https://doi.org/10.1136/bjo-2022-323162
R: A language and environment for statistical computing (2023) R Foundation for Statistical Computing, Vienna, Austria. [Online]. Available: https://www.R-project.org/
Angerer MPM, Weller JM, Kruse FE, Hille K (2024) Long-Term Outcomes of Keratoprosthesis With Biological Haptic: A Review of 25 Years of Single-Center Surgeries. Cornea 43(9):1137–1143. https://doi.org/10.1097/ICO.0000000000003495
Priddy J, Bardan AS, Tawfik HS, Liu C (2019) Systematic Review and Meta-Analysis of the Medium- and Long-Term Outcomes of the Boston Type 1 Keratoprosthesis. Cornea 38(11):1465–1473. https://doi.org/10.1097/ICO.0000000000002098
Zerbe BL, Belin MW, Ciolino JB, Boston G (2006) Results from the multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology 113(10):1779. https://doi.org/10.1016/j.ophtha.2006.05.015
Falcinelli G, Falsini B, Taloni M, Colliardo P, Falcinelli G (Oct2005) Modified osteo-odonto-keratoprosthesis for treatment of corneal blindness: long-term anatomical and functional outcomes in 181 cases. Arch Ophthalmol 123(10):1319–1329. https://doi.org/10.1001/archopht.123.10.1319
Wiedenmann CJ et al (2023) Indications, techniques, and graft survival of mini and corneo-scleral tectonic keratoplasties: A retrospective single-center case series. PLoS ONE 18(8):e0289601. https://doi.org/10.1371/journal.pone.0289601
Wang JY, Xie LX, Song XS, Zhao J (2011) Trends in the indications for penetrating keratoplasty in Shandong, 2005–2010. Int J Ophthalmol 4(5):492–497. https://doi.org/10.3980/j.issn.2222-3959.2011.05.07
Wang J, Hasenfus A, Schirra F, Bohle RM, Seitz B, Szentmary N (Mar2013) Changing indications for penetrating keratoplasty in Homburg/Saar from 2001 to 2010–histopathology of 1,200 corneal buttons. Graefes Arch Clin Exp Ophthalmol 251(3):797–802. https://doi.org/10.1007/s00417-012-2117-2
Matthaei M et al (2017) Changing Indications in Penetrating Keratoplasty: A Systematic Review of 34 Years of Global Reporting. Transplantation 101(6):1387–1399. https://doi.org/10.1097/TP.0000000000001281
Flockerzi E et al (2018) Trends in Corneal Transplantation from 2001 to 2016 in Germany: A Report of the DOG-Section Cornea and its Keratoplasty Registry. Am J Ophthalmol 188:91–98. https://doi.org/10.1016/j.ajo.2018.01.018
Daniel MC, Bohringer D, Lapp T, Maier PC, Reinhard T, Lang SJ (2021) [Keratoplasty in Germany: systematic analysis of the quality reports of German hospitals between 2006 and 2017]. Klin Monbl Augenheilkd 238(3):288–292. https://doi.org/10.1055/a-1035-9442. Die Keratoplastik in Deutschland: systematische Auswertung der Krankenhausqualitatsberichte der Jahre 2006 bis 2017
Lang SJ, Bischoff M, Bohringer D, Seitz B, Reinhard T (2014) Analysis of the changes in keratoplasty indications and preferred techniques. PLoS ONE 9(11):e112696. https://doi.org/10.1371/journal.pone.0112696
Pluzsik MT et al (2020) Changing Trends in Penetrating Keratoplasty Indications between 2011 and 2018 - Histopathology of 2123 Corneal Buttons in a Single Center in Germany. Curr Eye Res 45(10):1199–1204. https://doi.org/10.1080/02713683.2020.1737716
Williams KA, Keane MC (2022) Outcomes of corneal transplantation in Australia, in an era of lamellar keratoplasty. Clin Exp Ophthalmol 50(4):374–385. https://doi.org/10.1111/ceo.14089
Canadian Eye and Tissue Data Dashboard, Canadian Blood Services (2022) [Online]. Available: https://professionaleducation.blood.ca/en/organs-and-tissues/data-reports-and-publications/eye-and-tissue-reports-and-surveys. Accessed 19 Jun 2024
Eye banking statistical report, Eye Bank Association of America (2023) [Online]. Available: https://restoresight.org/members/publications/statistical-report/. Accessed 19 Jun 2024
Lang SJ, Böhringer D, Geerling G, Reinhard T (2017) Long-term results of allogenic penetrating limbo-keratoplasty: 20 years of experience. Eye (Lond) 31(3):372–378. https://doi.org/10.1038/eye.2016.217
Stark WJ, Leske MC, Worthen DM, Murray GC (1983) Trends in cataract surgery and intraocular lenses in the United States. Am J Ophthalmol 96(3):304–310. https://doi.org/10.1016/s0002-9394(14)77819-5
Seitz B, Daas L, Flockerzi E, Suffo S (2020) Descemet membrane endothelial keratoplasty DMEK - Donor and recipient step by step. Ophthalmologe 117(8):811–828. https://doi.org/10.1007/s00347-020-01134-1. (Descemetmembraneendothelialkeratoplasty"DMEK-SpenderundEmpfangerSchrittfurSchritt)
Funding
Open Access funding enabled and organized by Projekt DEAL. No funds, grants, or other support was received.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Jan Vincent Hoffmann, Daniel Böhringer and Stefan Lang. The first draft of the manuscript was written by Jan Vincent Hoffmann and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Competing interests
The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Hoffmann, J.V., Betancor, P.K., Maier, P. et al. Changing indications for keratoplasty: monocentric analysis of the past two decades. Graefes Arch Clin Exp Ophthalmol (2024). https://doi.org/10.1007/s00417-024-06639-y
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00417-024-06639-y